General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment

Completed

• Conditions: Pulmonary Disease, Chronic Obstructive

• Registration Number: NCT00319813
• Lead Sponsor: Boehringer Ingelheim

Brief Summary

A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04-19
• Study First Submitted: 2006-04-20
• Study First Posted: 2006-04-27
• Study First Submitted QC: 2006-04-28
• Primary Completion: 2007-09-05
• Study Completion: 2007-09-05
• Status Verified: 2023-11
• Last Update Submitted: 2023-11-30
• Last Update Posted: 2023-12-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8000

Inclusion Criteria

• COPD patients over 35 years of age
• More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these

Exclusion Criteria

• Asthma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To optimise the diagnosis and treatment of COPD via a quality assurance project	Up to 1.2 years
Increase the knowledge and use of diagnostic tools and treatment amongst PCPs	Up to 1.2 years
To focus on implementation of national guidelines for diagnosis and treatment of COPD	Up to 1.2 years